These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 3192979)
1. Leprosy control based on multi drug treatment in India. Rao CK; Mittal BN; Dharmshaktu NS Indian J Lepr; 1988 Apr; 60(2):290-302. PubMed ID: 3192979 [No Abstract] [Full Text] [Related]
2. Drug resistance and multi-drug therapy in leprosy. Chatterjee BR Indian J Lepr; 1989 Jul; 61(3):328-32. PubMed ID: 2768881 [No Abstract] [Full Text] [Related]
3. Comments on an editorial by B. R. Chatterjee "On Multi-Drug Combinations in the Treatment of Leprosy". Grosset JH; Baohang J; Noordeen SK Indian J Lepr; 1989 Jul; 61(3):323-7. PubMed ID: 2768880 [No Abstract] [Full Text] [Related]
4. Impact of multidrug therapy on leprosy in Baroda district (Gujarat). Chopra NK; Agarwal JS; Pandya PG Indian J Lepr; 1989 Apr; 61(2):179-89. PubMed ID: 2746026 [TBL] [Abstract][Full Text] [Related]
5. Rifampin 1200 mg once monthly together with daily Lamprene and dapsone in treatment of refactory patients with lepromatous leprosy. Paul S; Rose ET Int J Lepr Other Mycobact Dis; 1981 Sep; 49(3):342-3. PubMed ID: 7198625 [No Abstract] [Full Text] [Related]
6. Evaluation of multi-drug therapy for leprosy in the United States using daily rifampin. Dacso MM; Jacobson RR; Scollard DM; Stryjewska BM; Prestigiacomo JF South Med J; 2011 Oct; 104(10):689-94. PubMed ID: 21941157 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of multidrug therapy with rifampicin, clofazimine and D.D.S. in multibacillary leprosy cases. Kundu SK; Hazra SK; Chaudhury S; Chatterjee B Indian J Lepr; 1984; 56(1):78-85. PubMed ID: 6548246 [TBL] [Abstract][Full Text] [Related]
9. On multi-drug combinations in the treatment of leprosy. Chatterjee BR Indian J Lepr; 1988 Oct; 60(4):493-8. PubMed ID: 3253329 [No Abstract] [Full Text] [Related]
10. Parallel assessment of 24 monthly doses of rifampin, ofloxacin, and minocycline versus two years of World Health Organization multi-drug therapy for multi-bacillary leprosy. Villahermosa LG; Fajardo TT; Abalos RM; Cellona RV; Balagon MV; Dela Cruz EC; Tan EV; Walsh GP; Walsh DS Am J Trop Med Hyg; 2004 Feb; 70(2):197-200. PubMed ID: 14993633 [TBL] [Abstract][Full Text] [Related]
11. From vertical to integration for elimination: recent changes in the National Leprosy Eradication Programme in India. Thakar HG; Kumar A Indian J Public Health; 2003; 47(4):191-207. PubMed ID: 15125562 [No Abstract] [Full Text] [Related]
12. Once monthly rifampicin (1200 mg) plus daily dapsone (100 mg) and clofazimine (100 mg) in the initial treatment of lepromatous leprosy. Chandorkar AG; Burte NP; Gade RK; Bulakh PM Indian J Lepr; 1984; 56(1):63-70. PubMed ID: 6384381 [TBL] [Abstract][Full Text] [Related]
13. Multidrug therapy regimen for leprosy. Firooz A J Am Acad Dermatol; 2006 Dec; 55(6):1115; author reply 1115. PubMed ID: 17110233 [No Abstract] [Full Text] [Related]
14. Controlling the spread of leprosy--some observations on. Dharmendra Lepr India; 1976 Jul; 48(3):217-30. PubMed ID: 66418 [No Abstract] [Full Text] [Related]
15. Multi-drug therapy in bacilliferous leprosy--two years experience. Kaur S; Sharma VK; Kumar B; Singh M; Kaur I Indian J Lepr; 1985; 57(3):483-90. PubMed ID: 3831085 [TBL] [Abstract][Full Text] [Related]
16. Impact of multidrug therapy on the treatment and control of leprosy. Gilbody JS Int J Lepr Other Mycobact Dis; 1991 Sep; 59(3):458-78. PubMed ID: 1890370 [No Abstract] [Full Text] [Related]
17. [Combination drug therapy in leprosy]. Terencio de las Aguas J Acta Leprol; 1983; 1(3):143-50. PubMed ID: 6359802 [TBL] [Abstract][Full Text] [Related]
18. A retrospective study of the effect of modified multi-drug therapy in Nepali leprosy patients following the development of adverse effects due to dapsone. Sapkota BR; Shrestha K; Pandey B; Walker SL Lepr Rev; 2008 Dec; 79(4):425-8. PubMed ID: 19274989 [TBL] [Abstract][Full Text] [Related]
19. Influence of once-monthly rifampicin and daily clofazimine on the pharmacokinetics of dapsone in leprosy patients in Nigeria. Pieters FA; Woonink F; Zuidema J Eur J Clin Pharmacol; 1988; 34(1):73-6. PubMed ID: 3360051 [TBL] [Abstract][Full Text] [Related]
20. Short term combination therapy for paucibacillary leprosy--histological evaluation & follow-up study. Kumar B; Kaur S; Kaur I Indian J Lepr; 1987; 59(1):54-62. PubMed ID: 3302061 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]